Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Mohan M, Monge J, Shah N, Luan D, Forsberg M, Bhatlapenumarthi V, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, D'Souza A, Szabo A, Schinke C, Chakraborty R.
Mohan M, et al. Among authors: balev m.
Blood Cancer J. 2024 Mar 5;14(1):35. doi: 10.1038/s41408-024-01003-z.
Blood Cancer J. 2024.
PMID: 38443345
Free PMC article.